Focus Partners Wealth Boosts Holdings in GE HealthCare Technologies Inc. $GEHC

Key Points

• Focus Partners Wealth increased its stake in GE HealthCare Technologies by 7.2%, acquiring an additional 50,272 shares, bringing its total holdings to approximately 749,768 shares valued at about $60.5 million.
• The stock has received mixed ratings from analysts, with a consensus rating of "Moderate Buy" and a target price of $88.40, indicating confidence in future performance despite some price adjustments from individual firms.
• GE HealthCare Technologies recently reported a quarterly profit of $1.06 EPS, exceeding expectations, and set FY 2025 guidance around $4.430-4.630 EPS.

Focus Partners Wealth increased its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 7.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 749,768 shares of the company's stock after buying an additional 50,272 shares during the period. Focus Partners Wealth owned 0.16% of GE HealthCare Technologies worth $60,514,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. N.E.W. Advisory Services LLC purchased a new stake in GE HealthCare Technologies in the 1st quarter worth approximately $25,000. Bogart Wealth LLC grew its holdings in GE HealthCare Technologies by 260.0% in the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock worth $28,000 after acquiring an additional 247 shares during the last quarter. Stonebridge Financial Group LLC grew its holdings in GE HealthCare Technologies by 165.7% in the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock worth $29,000 after acquiring an additional 222 shares during the last quarter. Ameriflex Group Inc. bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at about $31,000. Finally, Olde Wealth Management LLC bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at about $35,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 1.9%

Shares of GE HealthCare Technologies stock traded down $1.52 on Friday, hitting $76.44. 3,254,120 shares of the company traded hands, compared to its average volume of 2,952,966. The company has a market cap of $34.90 billion, a PE ratio of 15.66, a PEG ratio of 2.98 and a beta of 1.13. The stock's 50 day moving average price is $74.46 and its 200-day moving average price is $73.54. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.15. The business had revenue of $5 billion for the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business's revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the previous year, the company earned $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio is currently 2.87%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on GEHC. Zacks Research raised shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 28th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a report on Thursday, July 31st. Morgan Stanley decreased their price objective on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. BTIG Research restated a "buy" rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Finally, Wall Street Zen upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, May 31st. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $88.40.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.